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Abstract
The genus Echinacea is a popular herbal immunomodulator. Recent reports indicate that
Echinacea products inhibit nitric oxide (NO) production in activated macrophages. In the present
study we determined the inhibitory effects of alcohol extracts and individual fractions of alcohol
extracts of Echinacea on NO production, and explored the mechanism underlying the
pharmacological anti-inflammatory activity. The alcohol extracts of three medicinal Echinacea
species, E. angustifolia, E. pallida and E. purpurea, significantly inhibited NO production by
lipopolysaccharide (LPS)-activated the RAW 264.7 macrophage cell line, among them E. pallida
was the most active. The Echinacea-mediated decrease in NO production was unlikely due to a direct
scavenging of NO because the extracts did not directly inhibit NO released from an NO donor, sodium
nitroprusside. An immunoblotting assay demonstrated that the extract of E. pallida inhibited
inducible nitric oxide synthase (iNOS) protein expression in LPS-treated macrophages. The enzymes
iNOS and arginase metabolize a common substrate, L-arginine, but produce distinct biological
effects. While iNOS is involved in inflammatory response and host defense, arginase participates
actively in anti-inflammatory activation. Arginase activity of RAW 264.7 cells stimulated with 8-
bromo-cAMP was significantly increased by alcohol extracts of all three Echinacea species. The
polar fraction containing caffeic acid derivatives enhanced arginase activity, while the lipophilic
fraction containing alkamides exhibited a potential of inhibiting NO production and iNOS expression.
These results suggest that the anti-inflammatory activity of Echinacea might be due to multiple active
metabolites, which work together to switch macrophage activation from classical activation towards
alternative activation.
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1. Introduction
The genus Echinacea, one of the top-selling botanical supplements, has been widely used for
centuries in North America and later in Europe for many therapeutic purposes. Although there
are nine known species of Echinacea, three of them, E. angustifolia (EA), E. pallida (EPA)
and E. purpurea (EP), are of similar and important medicinal values in the modulation of the
immune system (Borchers et al., 2000). These Echinacea species are rich in bioactive
metabolites of which lipophilic alkamides, water-soluble phenolic compounds (mainly caffeic
acid derivatives) and polysaccharides are the most recognized for their immunomodulatory
properties (Barnes et al., 2005). Although historically polysaccharides were considered critical
for stimulation of nonspecific immune responses (Borchers et al., 2000; Percival, 2000), recent
research focuses on the alkamides and caffeic acid derivatives. Caffeic acid derivatives are
good antioxidants in cell-free free radical generation systems (Hu and Kitts, 2000; Pellati et
al., 2004; Dalby-Brown et al., 2005) and echinacoside, the main caffeic acid derivative in EA
and EPA, has been functionally linked to anti-inflammatory and wound healing properties of
Echinacea when applied topically (Speroni et al., 2002; Rousseau et al., 2006).
Pharmacokinetic studies demonstrate that natural or synthesized caffeic acid derivatives (e.g.
caftaric acid, chlorogenic acid and echinacoside) are quickly absorbed in the rat stomach, but
rapidly eliminated from circulation (Jia et al., 2006; Lafay et al., 2006; Vanzo et al., 2007).
Matthias et al. (2004) suggests a low bioavailability for caffeic acid derivatives of
Echinacea based on their poor permeability through Caco-2 monolayers, a model for the
intestinal epithelial barrier. These data indicate that there may be a limited pharmacological
role for caffeic acid derivatives when consumed orally. In this regard, lipophilic alkamides,
which are considered orally bioavailable, may be more important phytochemicals (Matthias et
al., 2005; Woelkart et al., 2005a).
Echinacea-derived alkamides appear to have immunomodulatory and anti-inflammatory
activity (for review see Woelkart and Bauer, 2007). Both alkamide-containing Echinacea
extracts and purified alkamides inhibit production of proinflammatory tumor necrosis factor-
alpha (TNF-α) and nitric oxide (NO) in an activated murine macrophage cell line (Chen et al.,
2005; Matthias et al., 2007) with low cytotoxicity in vitro (Zhai et al., 2007a). Orally
administered alcohol extracts of Echinacea significantly decreased production of TNF-α and
interleukin (IL)-1βby activated splenocytes (Zhai et al., 2007b). Although Echinacea extracts
containing alkamides exhibit suppressive effects on these inflammatory mediators, the
underlying cellular mechanism is unclear.
Upon induction by certain inflammatory stimuli, e.g., bacterial lipopolysaccharide (LPS), the
NF-κB signal pathway activates and regulates the expression of a wide variety of genes
involved in inflammatory responses, e.g., the cytokines TNF-α and IL-1β, and the enzymes
inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (McKay and Cidlowski, 1999;
Yamamoto and Gaynor, 2001). The enzyme iNOS catalyzes the conversion of amino acid L-
arginine to NO, which is cytotoxic and cytostatic (Meurs et al., 2003). Although NO as an
active free radical and inflammatory mediator is part of the host defense, excessive production
of NO and its reactive nitrogen intermediates is involved in the pathogenesis of many chronic
diseases, such as inflammatory bowel disease, arthritis, atherosclerosis and tumors (Chan et
al., 2000; Yamamoto and Gaynor, 2001). Selective inhibition of the iNOS pathway is an
important strategy for control of many chronic inflammatory diseases (Chan et al., 2000).
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L-arginine metabolism can be redirected toward the synthesis of L-ornithine catalyzed by the
enzyme arginase. The subsequent products from L-ornithine, such as polyamines and L-
proline, are involved in cell growth, collagen synthesis and wound healing (Meurs et al.,
2003). Thus, arginase and iNOS are the two enzymes that catalyze a common substrate but
produce divergent biological effects. They are generally recognized to be functionally
competitive because the stimulation of one enzyme will negatively regulate the other one due
to the limited availability of the same substrate (Wang et al., 1995; Gotoh and Mori, 1999).
These two cross-regulated metabolic processes may reflect opposite functional states of
macrophages. It is well known that macrophages can be either classically activated or
alternatively activated, and are therefore termed as inflammatory or anti-inflammatory cells
(Munder et al., 1998; Porcheray et al., 2005). A given macrophage may switch from one
activated state to another upon a specific signal (Porcheray et al., 2005). Inflammatory
mediators and cytokines induce classical activation involving iNOS expression while anti-
inflammatory cytokines induce alternative activation with upregulated arginase activity
(Modolell et al., 1995; Munder et al., 1998; Yamamoto et al., 1998). Oral administration of
alcohol extracts of Echinacea to mice increases production of anti-inflammatory cytokines
IL-4 and IL-10, but decreases production of TNF-α and IL-1β in activated spleen cells (Zhai
et al., 2007b), suggesting that Echinacea may modulate macrophage function to be anti-
inflammatory via a decreased proinflammatory/anti-inflammatory cytokine ratio. Thus, we
hypothesized that Echinacea can perturb the iNOS/arginase balance in macrophages in favor
of increasing arginase activity for alternative anti-inflammatory activation.
In this study, we examined the effects of Echinacea extracts and their fractions on the
production of NO in activated macrophage cell line as well as the cellular mode of action
underlying the biological activity. We found that alcohol extracts of Echinacea had opposite
effects on NO production and arginase activity, and these differential effects were induced by
different fractions (or chemical constituents), which could work coordinately to drive
macrophages to alternative activation.
2. Materials and methods
2.1. Preparation of alcohol extracts
Dried powdered roots of EA, EPA and EP harvested in 2003 were provided by Iowa State
University Botanical Supplements Research Center; and by the USDA North Central Regional
Plant Introduction Station in Ames, Iowa, with accession numbers PI 631285, PI 631293, and
PI 631307, respectively. Alcohol extracts from the root powders of these plants were prepared
as previously described (Zhai et al., 2007b). The extracts were diluted to 20 mg/ml in PBS
containing 5% ethanol. Aliquots of the dilutions were stored at −80°C for up to 2.5 years during
which no obvious herbal efficacy was reduced.
2.2. Fractionation of alcohol extracts
For fractionation, the dried powdered roots of the plants harvested in 2005 (EA) or 2006 (EPA
and EP) were used to prepare new alcohol extracts using the Soxhlet extraction. The dry
residues were redissolved in 75% ethanol to obtain ≤ 0.6 g/ml. Five milliliters were injected
into a semi-preparative high performance liquid chromatography (HPLC). The starting
conditions of the semi-preparative HPLC was 90% Pump A, which was 0.1% acetic acid, and
10% Pump B, which was acetonitrile at a flow rate of 3 ml/min. Eluent was collected over time
with increasing solvent B as outlined in Table 1A. The gap of 1–2 minutes between fractions
indicated the time of stopping the flow of the mobile phase for the change of the collection
flasks. The fractions were evaporated to remove the mobile phase and lyophilized. Each
lyophilized fraction was dissolved and diluted to 4 mg/ml in PBS containing 25% ethanol, and
aliquots were kept at −80°C and used within one year.
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2.3. Phytochemical analysis
The phytochemical analysis was performed to detect bioactive metabolites of alkamides and
caffeic acid derivatives in the crude alcohol extracts with the use of HPLC as described
previously (Wu et al., 2004). We did not identify ketones as no internal standards for ketones
were used. However, ketones are expected to be present as lipophilic compounds and
concomitantly appear in alkamide fractions of EPA (Chicca et al., 2008).
Fractions were identified as described by Liu and Murphy (2007). The mobile phase used for
the analytical HPLC method was, Pump A: 0.1% acetic acid; and Pump B, acetonitrile. At a
flow rate of 1 ml/min, a UV scan was collected in the range of 190–600 nm. Alkamides were
viewed at 260 nm, while caffeic acid derivatives were viewed at 330 nm.
Peak identification was based on relative retention time, similarity of UV spectra, internal
standards, spiking and chromatogram fingerprinting (Wu et al., 2004; Liu and Murphy,
2007). Individual standards were run to check for relative retention times and UV spectra. An
EP sample with identified peaks was also run to obtain the finger print of the chromatogram,
the relative retention times of the alkamides and caffeic acid derivatives, and to obtain the UV
spectra of identified compounds.
2.4. Determination of endotoxin in herbal preparations
All glassware used in the extraction and fractionation procedure was baked at 185°C overnight
prior to use in order to minimize endotoxin contamination. Endotoxin-free Nanopure water
was used for preparation and dilution of crude alcohol extracts and fractions. The endotoxin
levels were evaluated in aliquots of the herbal preparations using the Limulus Amebocyte
Lysate Test (Cambrex Bio Science Walkersville, Inc., Walkersville, MD, USA) according to
the manufacturer’s specifications for a microplate assay, and were found to be below the limit
of detection (< 0.1 EU/ml).
2.5. Macrophage cell line
The murine peritoneal macrophage cell line RAW 264.7 cells were obtained from American
Type Culture Collection (ATCC, Rockville, MD, USA) and grown in RPMI 1640 medium
(GIBCO, Invitrogen Corporation, Grand island, NY, USA) supplemented with 2 mM
glutamine, 25 mM Hepes, 50 μg/ml gentamicin and 10% heated-inactivated iron-fortified
bovine calf serum (JRH Biosciences, Lenexa, KS, USA) at 37°C in a 7% CO2 incubator. Cells
between passage 5 and 20 (Kiemer et al., 2002) were used in this study.
2.6. NO and TNF-αassays
RAW 264.7 cells (8×104 cells/well) were seeded in flat bottom 96-well tissue culture plates
(Corning Inc., Corning, NY, USA) in the presence or absence of various concentrations of
Echinacea preparations (as indicated in each graph) and/or LPS (E. coli 055:B5; Sigma, St.
Louis, MO, USA). Final concentration of ethanol used as a solvent of lipophilic metabolites
in each well was 0.25% (v/v). Ethanol (0.25%) control wells were tested in parallel. After 23
h incubation, culture supernates were collected for NO and TNF-α assays, and the attached
cells were evaluated for viability (see below).
In a second set of experiments, Echinacea extracts (100 μg/ml) were either added
simultaneously with LPS (1 μg/ml) or up to 6 h after LPS addition (Kiemer et al., 2002). Culture
supernates from cells activated with LPS for 22 h were collected for NO assay.
Nitrite, a stable NO metabolite, was determined by the method of Griess reaction (Park et al.,
2005). A trace amount of nitrite present in cell-free culture medium was subtracted from each
value obtained with cells. Sodium nitrite (0.39–100 μM) was used as a standard. It was
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confirmed that Echinacea extracts at 200 μg/ml did not interact with nitrite and interfere with
its detection (data not shown).
TNF-α was assayed by BD OptEIA ELISA set (BD Biosciences, San Diego, CA, USA). The
cytokine levels were calculated by using a purified recombinant mouse cytokine as a standard.
2.7. Scavenging of NO production from NO donor
Sodium nitroprusside (SNP), an NO donor, in aqueous solution at physiological pH
spontaneously liberates NO, which rapidly interacts with oxygen to produce nitrite (Sreejayan
and Rao, 1997; Chan et al., 2000; Kiemer et al., 2002). In order to determine if Echinacea
metabolites directly interact with NO, SNP (final concentration 2.5 mM; Sigma) was mixed
with the Griess reagent (Park et al., 2005) in the presence of 0.25% ethanol or various
concentrations of alcohol extracts, and then incubated at room temperature for a set of time
points. NO released from SNP in this reaction system was immediately captured by Griess
reagent via nitrite, which was sequentially monitored on a plate reader (Bio-Tek Instruments,
Winooski, VT, USA). A series of sodium nitrite standard concentrations instead of SNP was
set up and measured at the same time. The reading of the standard curve remained stable
throughout the observational period.
2.8. Determination of arginase activity
Arginase activity was determined according to a microplate method (Corraliza et al., 1994;
Munder et al., 1998) with slight changes. RAW 264.7 cells (4×105 cells/ml) were incubated
in 96-well tissue culture plates in the presence or absence of LPS (1 μg/ml), 8-bromo-cAMP
(0.25 mM; Sigma) and/or Echinacea preparations. After 23–24 h incubation, supernates were
collected for NO assay, the cells rinsed with PBS, and then lysed with a CelLytic M lysis
solution (Sigma). Following centrifugation at 2,500 × g for 5 min at 4°C, 50 μl of the lysate
was mixed with 40 μl of 25 mM Tris-HCl (pH 7.4) and 10 μl of 10 mM MnCl2. The arginase
was activated by heating for 10 min at 56°C. Aginine hydrolysis to urea was conducted by
addition of 100 μl of 0.5 M L-arginine (Sigma), pH 9.7, with incubation at 37°C for 60 min.
The reaction was stopped with 800 μl of H2SO4 (96%)/H3PO4 (85%)/H2O (1/3/7, v/v/v). The
urea concentration was measured at 550 nm after addition of 40 μl of 9% (w/v) α-
isonitrosopropiophenone (Sigma) dissolved in 100% ethanol and heating at 95°C for 90 min.
A standard curve was performed with 2-fold dilutions of urea (0.03–4 mM) followed by mixing
with the stop reagent and heating. One unit of arginase activity is defined as the amount of
enzyme that catalyzes the formation of 1 μmol urea per min at 37°C. Protein concentrations in
cell lysate were determined using a micro BCA (Bicinchoninic Acid) protein assay (Pierce
Labs, Rockford, IL, USA).
2.9. Western blotting analysis
RAW 264.7 cells (5×105 cells/well) were seeded in 24-well plates in the presence or absence
of LPS (1 μg/ml) and various Echinacea preparations. After 24 h incubation, cells were rinsed
with ice-cold PBS and lysed with the CelLytic M lysis solution containing 1% (v/v) protease
inhibitor cocktail (Sigma). Cell debris was removed by centrifugation (12,000 × g for 15 min),
and the resultant supernates were stored at −80°C untill use. The thawed cell lysates were mixed
with 4× NuPAGE SDS sample loading buffer (Invitrogen). Equal amounts of cellular protein
(25 μg/lane) were separated on 10% Tris-HCl ready gel (Bio-Rad Laboratories, Hercules, CA,
USA), followed by electrotransfer onto a PVDF plus membrane. The immunoblot was
performed by incubation with rabbit polyclonal anti-iNOS (1:500 dilution) (sc-8310, Santa
Cruz Biotechnology Inc., Santa Cruz, CA, USA) in 5% non-fat milk in PBS/0.1% Tween-20
(PBST) overnight at 4°C, followed by incubation with horseradish peroxidase-conjugated
donkey anti-rabbit IgG (1:2500 dilution) (Santa Cruz Biotechnology Inc.) for 1 h at room
temperature. The bands were visualized using an amplified Opti-4CN Substrate kit (Bio-Rad
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Laboratories). The blots were photographed and the band density quantified with Kodak Image
Station 440 CF and Kodak 1D image analysis software (Eastman Kodak Company, Rochester,
NY, USA). To assess the changes of iNOS expression and to normalize protein loading,
membranes run in parallel were incubated with mouse monoclonal antibody against β-actin
(1:5000 dilution) (Santa Cruz Biotechnology Inc.).
2.10. Cell viability assay
Mitochondrial reduction of MTS, a tetrazolium compound, to a colored formazan was used as
an indicator of cell viability (Cory et al., 1991). Briefly, after removing of 100 μl of culture
supernates (i.e. for NO and TNF-α assays), 15 μl of MTS (CellTiter 96 Aqueous One Solution
Cell Proliferation Assay, Promega Corporation, Madison, WI, USA) was added to the
remaining 100 μl of culture medium incubation continued for 1 h. The extent of formazan
formation was determined photometrically at absorbance 490 nm on a plate reader. The
absorbance of cell-free culture medium with or without vehicle or Echinacea preparations was
used as a blank (self-control) and subtracted from the value of the corresponding treatment
groups.
2.11. Statistical analysis
Statistix software (version 8.0, Analytical Software, Tallahasee, FL, USA) was used for the
statistical analysis. Differences between the vehicle and other groups were tested by two-way
analysis of variance (group × experiment). A value P<0.05 was considered significant.
3. Results
3.1. Phytochemical analysis
Table 2 lists the amounts of total alkamides and several important caffeic acid derivatives in
crude alcohol extracts of three Echinacea species.
The chemical constituents in the fractions are shown in Table 1B. Fraction 1 was rich in polar
caffeic acid derivatives. Fraction 3 contained lipophilic constituents including alkamides (in
all three species) and ketones (in EPA). Other hydrophobic compounds were found in fractions
4 and 5. For fractions 3–5, the later fractions contained compounds which are more hydrophobic
than the earlier ones.
3.2. Inhibition of TNF-αproduction by alcohol extracts
As TNF-α production was regulated by Echinacea in vivo (Zhai et al., 2007b), we measured
this cytokine in Echinacea-treated RAW 264.7 cells. In the absence of LPS, very low amounts
(or lower than limit of detection, 15 pg/ml) of TNF-α were measured in the supernates from
RAW 264.7 cells incubated with or without alcohol extracts of Echinacea overnight. In the
presence of LPS, the cells secrete high levels of TNF-α. Vehicle (0.25% ethanol) alone had no
effect on the cytokine production, however, all three alcohol extracts at a concentration of 100
μg/ml significantly inhibited TNF-α production (P values <0.001, Fig. 1A). The inhibitory
effects of Echinacea extracts in the presence of 0.1 μg/ml LPS were dose-dependent as
indicated by a significant linear effect of dose (P values <0.05) (Fig. 1B). Alcohol extracts of
Echinacea at the test concentration range of 10–200 μg/ml had little effect on cell viability
based on the MTS assay (Fig. 1B), indicating that the inhibitory effect of Echinacea extracts
on TNF-α is unlikely due to cytotoxicity.
3.3. Inhibition of NO production by alcohol extracts
In the absence of LPS, less than 0.5 μM of NO was detectable in culture medium of RAW
264.7 cells incubated in vitro for 23 h. In the presence of increasing concentrations of LPS,
Zhai et al. Page 6
J Ethnopharmacol. Author manuscript; available in PMC 2010 February 25.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
cells produce NO, which reached a maximum with LPS at 1 μg/ml (Fig. 2A). Exposure to
vehicle had no effect on NO production, however, the three Echinacea extracts at 100 μg/ml
reduced NO production. The inhibitory effect of Echinacea extracts on NO production was
dose-dependent as indicated by a significant linear effect of dose (P values <0.008) (Fig. 2B).
At 100 μg/ml, the inhibitory potential of three species extracts in the presence of 1 μg/ml LPS
is generally EPA > EP > EA. All three extracts at tested concentrations had no effect on cell
viability (Fig. 2B).
3.4. Direct scavenging of NO generated by alcohol extracts
NO production was estimated by measuring nitrite using the Griess reaction system. NO
derived from SNP increased in a linear time-dependent manner (Fig. 3A). Vehicle alone had
no any effect on the NO production, but alcohol extracts of EA and EPA at a final concentration
of 50 μg/ml significantly inhibited nitrite accumulation beginning 120 min after initiating of
the reaction (Fig. 3A) (P values <0.018 at 120-min time points). However, the inhibitory rates
of NO production by these two extracts throughout the 3-h observation period were small
(<15%), and were not concentration-dependent (Fig. 3B). EP extracts at lower concentrations
of 5–25 μg/ml, but not at higher concentrations (50–200 μg/ml), significantly reduced nitrite
accumulation (P values <0.015).
3.5. Inhibition of iNOS induction by alcohol extracts
Effects of alcohol extracts on iNOS induction were measured by an indirect method described
by Kiemer et al. (2002). Once macrophages are activated, iNOS gene transcription is initiated
about 1 h after activation, whereas its protein expression occurs some 3–4 h later. If the
Echinacea-mediated decrease in NO production is through interference with the transcriptional
induction process, earlier treatment (i.e. 0.5 h after LPS stimulation) with Echinacea extracts
should have a more profound effect on NO production than adding the extracts later. Therefore,
in these experiments, alcohol extracts (100 μg/ml) were either added simultaneously with LPS
(1 μg/ml) or up to 6 h after addition of LPS. The results showed that after LPS activation, the
earlier addition of alcohol extracts resulted in more inhibition of NO production (Fig. 4),
indicating that Echinacea inhibits the transcriptional induction of iNOS. Of three alcohol
extracts, EPA extract was the most active, in agreement with its strongest inhibitory potential
of TNF-α and NO production.
3.6. Opposite regulation of NO production and arginase activity by alcohol extracts
Raw 264.7 cells were incubated with alcohol extracts in the presence or absence of LPS to
stimulate iNOS and/or 8-bromo-cAMP to induce arginase activity (Morris et al., 1998). The
induction of arginase activity by 8-bromo-cAMP was further enhanced by the addition of LPS,
which itself is a weak stimulant of arginase. In the presence of LPS alone, alcohol extracts of
EP and EPA at 100 μg/ml significantly inhibited NO production (P values <0.05) (Fig. 5A),
but their influence on arginase activity did not reach statistical significance. Note that 8-bromo-
cAMP alone did not induce NO production, but decreased the NO production when added with
LPS to RAW 264.7 cells. Moreover, all three alcohol extracts induced additional suppression
of NO production in conjunction with 8-bromo-cAMP. In the presence of 8-bromo-cAMP, the
three Echinacea extracts at 100 μg/ml significantly increased arginase activity up to 2-fold
(P values <0.001) (Fig. 5B). The enhancing effect of Echinacea extracts on arginase activity
was also seen when both 8-bromo-cAMP and LPS were present in the culture medium (Fig.
5B). When the concentrations of Echinacea extracts were reduced to 10 μg/ml, an enhancing
effect was still seen when cells were exposed to Echinacea extracts (Fig. 5C). The test dose
range (10–200 μg/ml) of Echinacea extracts had no effect on cell viability (Fig. 5C).
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3.7. Differential regulation of NO production and arginase activity by fractions
In order to understand if the same fractions that inhibited NO production are responsible for
increased arginase activity, five fractions of alcohol extracts were prepared (Table 1).
Generally, the HPLC fractions of the three Echinacea extracts exhibited very similar patterns
of effects on NO production and arginase actvity. Note that the opposite effects of
Echinacea extracts on NO production and arginase activity resulted from different fractions.
For all three species of Echinacea, fraction 3 containing abundant alkamides had robust
inhibition of NO production. For EA, NO was also suppressed by fraction 4 with greater
suppression by fraction 5, and for EP, there is some NO suppression by all fractions with the
greatest suppression by fractions 2, 3, and 5 (Fig. 6A). On the other hand, the polar fractions
(fractions 1) induced increased arginase activity (Fig. 6B). However for EPA, the greatest
enhancement of arginase activity was seen with fraction 4 which contains unidentified
hydrophobic compounds. The HPLC fractions of alcohol extracts showed no cytotoxicity as
indicated by the MTS assay (data not shown).
3.8. Inhibition of iNOS protein expression
Decreased NO production might be relative to decreased iNOS protein expression as indirectly
indicated in Figure 4. To that end, we carried out Western blot analysis of lysates of cells
exposed to alcohol extracts of three Echinacea species at 100 μg/ml or their fractions at 25
μg/ml for 24 h in the presence of LPS. For EA, iNOS expression was significantly inhibited
by fractions 3, 4 and 5 (P values <0.05). For EPA, the unfractionated alcohol extract and its
fraction 3 had a robust inhibiting activity (P values <0.05). The unfractionated alcohol extract
of EP and its fractions all showed, to some extent, an inhibiting effect, but they did not reach
statistical significance except for fraction 5 (P = 0.046).
4. Discussion
NO and TNF-α are two key mediators in host defence and inflammatory response. They
positively regulate each other (Yamamoto and Gaynor, 2001; Wu et al., 2003) and therefore
amplify inflammatory signals. However, improper upregulation of these inflammatory players
are implicated in a pathological role in inflammatory processes (Yamamoto and Gaynor,
2001; Kiemer et al., 2002). Our results demonstrated the suppressive effects of Echinacea
extracts and certain individual fractions on production of NO and TNF-α in an activated
macrophage cell line, in accordance with previous in vitro observations (Chen et al., 2005;
Matthias et al., 2007; Zhai et al., 2007a). In order to understand the cellular mechanism as well
as the biological implication underlying the herbal anti-inflammatory activity, we carried out
additional experiments. We focused our interest on the mechanistic basis for decreased NO
production because NO is an important effector molecule in the classical activation of
macrophages (MacMicking et al., 1997; Munder et al., 1998).
Macrophages metabolize arginine to produce either NO through iNOS or ornithine through
arginase. These two metabolic processes have important yet divergent roles in the cellular
function. NO functions primarily with cytotoxic and cytostatic activity while the products of
arginase pathway promote cell proliferation (Meurs et al., 2003). The predominance of one
pathway over the other may rest on the presence of desirable inducers in the microenvironment.
Macrophages express two arginase isoforms with distinct subcellular localizations: cytosolic
type I and mitochondrial type II (Louis et al., 1999). LPS co-induces iNOS and arginase II, but
the arginase II expression lags behind iNOS expression (Wang et al., 1995; Morris et al.,
1998; Gotoh and Mori, 1999). The delayed expression of arginase II helps control NO
production, and prevent NO-induced cell apoptosis (Munder et al., 1998; Gotoh and Mori,
1999). We hypothesized that an Echinacea-mediated decrease in NO production implies an
increased activity of arginase in activated macrophages. As expected, Echinacea extracts
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oppositely regulated NO production and arginase activity even though the determinations of
these two parameters were performed with different inducers (LPS or 8-bromo-cAMP). This
differential regulation of two cross-regulated metabolic processes by Echinacea species may
have important implications in the anti-inflammatory activity.
Although we predicted that one fraction responsible for decreased NO production would also
be a strong stimulant of arginase, we observed the opposite regulatory effects on NO production
and arginase activity were due to different fractions. Lipophilic fraction 3 was found to be the
most effective in suppressing NO production while the polar fraction containing caffeic acid
derivatives was an inducer of arginase activity, though the polar metabolites from EPA only
showed an increasing trend in arginase activity. It is not surprising that the lipophilic fractions
mediated a decrease in NO production, since an anti-inflammatory effect of alkamides has been
reported (Chen et al., 2005; Matthias et al., 2007). Rather, it is noteworthy that caffeic acid
derivatives (fraction 1) from EA and EPA have no effects on NO production considering that
they are well demonstrated antioxidants (Hu and Kitts, 2000; Pellati et al., 2004; Dalby-Brown
et al., 2005). Some natural antioxidants (e.g., flavonoids, resveratrol and curcumin) have been
found to have strong inhibitory effects on iNOS expression and NO production in activated
macrophages (Surh et al., 2001; Yamamoto and Gaynor, 2001).
Although caffeic acid derivatives have been determined to penetrate poorly across Caco-2
monolayers (Matthias et al., 2004), in vitro they enter into cells to accumulate high enough
concentrations and consequently affect arginase activity. Cyclic AMP-stimulated arginase
expression is through a complicated signal pathway involving intracellular activation of protein
kinase A (Chang et al., 2000), and it has been proposed that Th2 cytokine-induced increase in
arginase activity is cAMP-dependent (Corraliza et al., 1997; Wei et al., 2000). Although we
can not answer based on the present data if caffeic acid derivatives directly mediate the
activation of protein kinase A pathway, they may affect the signal pathway by upregulating
Th2 cytokines, such as IL-4 and IL-10, as oral administration of Echinacea-mediates an
increase in Th2 cytokines (Zhai et al., 2007b).
The lipophilic fraction of EPA includes two classes of phytochemicals, alkamides and ketones.
While alkamides are widely investigated, ketones are almost completely neglected. Ketones
are, in fact, the main lipophilic constituents in EPA roots, and ketone 23 is recognized as the
diagnostic marker for hydrophobic metabolites (Kraus et al., 2005). The biological activity of
ketones from EPA is little known. It has been suggested that ketones have antifungal activity
(Binns et al., 2000). Obviously, like other bioactive metabolites of Echinacea (Awang,
1999), the antifungal activity of ketones may be through modulation of immune cell function
rather than through a direct fungal killing. For lipophilic fraction 3 of EPA, it is possible that
in addition to alkamides, ketones play a role in the regulation of NO production.
NO reacts rapidly with oxygen to form nitrogen dioxide, a gas capable of inducing cell damage
(Meurs et al., 2003). It has been suggested that the polar caffeic acid derivatives of
Echinacea possess an antioxidant and radical scavenging nature (Hu and Kitt, 2000; Pellati et
al., 2004; Dalby-Brown et al., 2005), which could be enhanced by lipophilic alkamides (Dalby-
Brown et al., 2005). However, Echinacea extracts (a mixture of caffeic acid derivatives and
alkamides) did not scavenge or interact with NO and nitrogen dioxide species directly.
Moreover, Echinacea extracts did not strongly inhibit nitrite accumulation by competing with
oxygen to react with NO generated from SNP. Additionally, Echinacea extracts could not
effectively protect RAW 264.7 cells from SNP-induced cell damage or cytotoxicity via the
release of high levels of NO (data not shown). Based on these collected data, we could conclude
that Echinacea-mediated decrease in NO production by macrophages is mainly via the
modulation of the production yield of NO, but not direct scavenging of NO.
Zhai et al. Page 9
J Ethnopharmacol. Author manuscript; available in PMC 2010 February 25.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Echinacea present at the onset of LPS-induced iNOS expression resulted in a stronger
inhibitory effect on NO production, suggesting that Echinacea could block the LPS-initiated
upstream signaling pathway. Sharma et al. (2006) demonstrated that an alcohol tincture of EP
roots significantly inhibited the nuclear expression of multiple pro-inflammatory transcription
factors including NF-κB and STATs in a viral infection model. Others showed that in
stimulated macrophages, certain individual alkamides could inhibit NF-κB activity (Matthias
et al., 2007). Down-regulation of NF-κB expression will lead to decreased iNOS expression
and NO production. Our results suggested that the Echinacea-mediated decrease in NO
production was generally associated with decreased protein expression of iNOS as indicated
by Western blotting assay. The control protein β-actin was not affected under the same
conditions suggesting that Echinacea-mediated inhibition of iNOS expression did not result
simply from a broad decrease in protein expression. Note that several Echinacea preparations
showed relatively weak inhibition of iNOS protein expression when compared with their
effects on NO production, this may suggest other mechanisms in the context of decreased NO
production, i.e. a direct inhibition of iNOS enzyme activity. However, NO production
correlates with iNOS activity and is commonly used as an indirect indicator of iNOS activity
(Wang et al., 1995; Munder et al., 1998). In addition, decreased NO production might be in
part due to a switch of macrophage function to alternative activation, leading to less availability
of the substrate for the iNOS pathway.
Echinacea-derived alkamides have been found recently to regulate cellular signaling and
immune responses involving the endocannabinoid system. Interestingly, alkamides have a
structural similarity with anandamide, an endogenous cannabinoid (CB) receptor ligand.
Alkamides showed anandamide-like activities by binding to CB2 receptors highly expressed
on immune cells and CB1 receptors predominantly expressed in the brain (Gertsch et al.,
2004; Woelkart et al., 2005b; Raduner et al., 2006). This is the first molecular target identified
for Echinacea so far. The endocannabinoid system involves many pathophysiological activities
including anti-inflammation and analgesic action. The finding of the interaction of alkamides
with CB receptors may help explain the traditional use of Echinacea in phytotherapy for wound
healing, pain relief and alleviation of cold symptoms. Naturally occurring alkamides may have
other therapeutic targets besides the endocannabinoid system (Gertsch et al., 2008; Raduner
et al., 2006).
Taken together, Echinacea affects macrophage immune function at multiple levels, resulting
in inhibition of NO production and increased arginase activity. Observations on fractions of
alcohol extracts of Echinacea indicate that Echinacea-mediated decrease in NO production is
due to bioactive alkamides. Such in vitro effects may be directly applicable to in vivo
administration as alkamides are bioavailable. Moreover, the anti-inflammatory activity of
Echinacea might be dependent on a synergistic action of both alkamides and caffeic acid
derivatives, which act together to drive macrophages to alternative activation. These
noteworthy findings will help define the mechanisms behind the success of traditional use of
Echinacea in phytotherapy for inflammatory diseases.
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Fig. 1.
Alcohol extracts of Echinacea inhibit production of TNF-α by LPS-stimulated macrophages.
RAW 264.7 cells were incubated in vitro for 23 h in the presence of indicated Echinacea
extracts 100 μg/ml plus different concentrations of LPS (A), or incubated with different
concentrations of Echinacea extracts (0–200 μg/ml) in the presence of 0.1μg/ml LPS (B).
Culture supernates were assayed for TNF-α by ELISA(A and B (solid lines)). The attached
cells were evaluated for cell viability by MTS assay (B (dashed lines)). The data are expressed
as mean ± standard error of the mean of 3 independent experiments performed in triplicate.
*P<0.001 vs the vehicle control at the same concentration of LPS.
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Fig. 2.
Alcohol extracts of Echinacea inhibit production of NO by LPS-stimulated macrophages. Cells
were incubated in vitro for 23 h in the presence of Echinacea extracts 100 μg/ml plus different
concentrations of LPS (A), or incubated overnight with different concentrations of indicated
Echinacea extracts (0–200 μg/ml) in the presence of 1 μg/ml LPS (B). After removing
supernates for NO assay (A and B (solid lines)), cell viability was evaluated by addition of
MTS (B (dashed lines)). The data are expressed as mean ± standard error of the mean of 3
independent experiments performed in triplicate.
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Fig. 3.
Scavenging of NO derived from SNP by alcohol extracts of Echinacea. A. SNP was mixed
with Griess reagent in the presence of vehicle (0.25% ethanol) or 50 μg/ml of Echinacea
extracts and incubated for 6 h. Nitrite accumulation was monitored at 550nm at various time
points and calculated based on the absorbance of sodium nitrite standards manipulated in the
same way with Griess reagent. B. SNP was mixed with Griess reagents containing various
concentrations of Echinacea extracts and then incubated for 150 min. The data are expressed
as mean ± standard error of the mean of 3 independent experiments performed in triplicate.
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Fig. 4.
Time course of inhibition of NO production by alcohol extracts of Echinacea. Echinacea
extracts (100 μg/ml) were either added simultaneously with LPS (1 μg/ml) (0 h) or up to 6 h
after addition of LPS. The nitrite accumulation by RAW 264.7 cells was determined 22 h after
LPS stimulation by the Griess reaction. The data are expressed as mean ± standard error of the
mean of 4 experiments performed in triplicate. *P<0.05 and **P<0.001 vs 0.25% ethanol in
the presence of LPS (control). +P<0.05 and ++P<0.001 vs respective group in the presence of
LPS at time point 0 h.
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Fig. 5.
Regulation of NO production and arginase activity of activated RAW 264.7cells by alcohol
extracts of Echinacea. Cells were incubated in the presence or absence of indicated
concentrations of Echinacea extracts, LPS (1 μg/ml) and/or 8-bromo-cAMP (abbreviated
cAMP, 0.25 mM) for 23–24 h, then supernates were collected for NO assay (A). The cell lysates
were assayed for arginase activity (B and C (solid lines)) as described in Materials and Methods.
Cell viability was determined by MTS assay (C (dashed lines)). Data are mean ± standard error
of the mean of 4–5 experiments performed in triplicate (for NO and cell viability) or duplicate
(arginase). *P<0.05 and **P<0.001 vs 0.25% ethanol as control in respective treatment group.
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Fig. 6.
Regulation of NO production and arginase activity of activated RAW 264.7 cells by fractions
of alcohol extracts of Echinacea. NO production was determined in supernates of cells exposed
to LPS (1 μg/ml) plus individual fraction (25 μg/ml) for 24 h (A). Arginase activity was assayed
in cells treated with LPS (1 μg/ml), 8-bromo-cAMP (0.25 mM) and individual fraction (25
μg/ml) for 24 h (B). Data are expressed as mean ± standard error of the mean of 4–5 experiments
performed in triplicate (NO) or duplicate (arginase). *P<0.05 and **P<0.001 vs 0.25% ethanol
as vehicle as in respective treatment group.
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Fig. 7.
Regulation of iNOS expession by alcohol extracts and fractions of Echinacea. Cells were
incubated with or without LPS (1 μg/ml) plus Echinacea extract (100 μg/ml) or individual
fraction (25 μg/ml) for 24 h. The iNOS expression was analyzed by Western blotting and
digitally quantitated using image analysis software. The data represent the mean of three
independent experiments with different cell preparations. Representative bands are shown. The
net intensity of iNOS bands was compared to that of corresponding β-actin with the same
treatment, and the ratio was expressed as a percent of the ratio for the vehicle- and LPS-treated
cells. A. EA; B. EPA; C. EP. *P<0.05 vs vehicle plus LPS.
Zhai et al. Page 20
J Ethnopharmacol. Author manuscript; available in PMC 2010 February 25.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Zhai et al. Page 21
Table 1
A. Fractionation procedure using semi-preparative HPLC
Retention time (min) Solvent Aa Solvent Bb Fraction
0–31 90–70% 10–30% 1
33–42 70–60% 30–40% 2
43–83 60–20% 40–80% 3
84–94 20–0% 80–100% 4
95–115 0% 100% 5
B. Echinacea fractions and their chemical constituents
Fraction Species
E. angustifolia E. pallida E. purpurea
1 Caffeic acid derivatives Caffeic acid derivatives Caffeic acid derivatives
2 Unknown Unknown Unknown
3 Alkamides Alkamides and ketones Alkamides
4 Alkamide 11 and other very
hydrophobic compounds
Very Hydrophobic compounds Very hydrophobic compounds
5 Most hydrophobic compounds Most hydrophobic compounds Most hydrophobic compounds
a
Solvent A: 0.1% acetic acid
b
Solvent B: acetonitrile
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Table 2
Concentrations of known metabolites in alcohol extracts of Echinacea
Metabolites
Species
E. angustifolia E. pallida E. purpurea
Amides 1.71a 1.04 2.61
Caftaric acid ND 0.06 0.06
Chlorogenic acid 0.09 0.21 ND
Cichloric acid NDb 0.06 0.46
Echinacoside 0.39 1.26 ND
a
% of dried extract
b
ND = not detectable
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